Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Document Period End Date	Mar. 31, 2016
Cash flows from operating activities:
Net Income (Loss) Attributable to Parent	$ 22,159,000	$ 18,336,000
Net Income (Loss) Attributable to Noncontrolling Interest	192,000	0
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	2,720,000	2,597,000
Benefit for deferred taxes	(165,000)	(161,000)
Share based compensation	647,000	458,000
Provision for doubtful accounts	(241,000)	9,000
Debt discount amortization on convertible debt	0	7,000
Unrealized foreign exchange gain	(48,000)	(672,000)
Capitalized Computer Software, Amortization	326,000	0
Reduction of acquisition earnout accruals	(511,000)	0
Changes in assets and liabilities, net of effects from acquisitions:
Accounts receivable	(8,669,000)	(4,689,000)
Other assets	(220,000)	(1,250,000)
Accounts payable and accrued expenses	(7,563,000)	(21,215,000)
Accrued payroll and related benefits	717,000	(564,000)
Deferred revenue	1,258,000	308,000
Deferred rent	(80,000)	(68,000)
Unrecognized tax benefits, period increase (decrease)	50,000	87,000
Loss Contingency Accrual, Period Increase (Decrease)	0	(690,000)
Other current liabilities	(38,000)	165,000
Net cash provided by operating activities	10,534,000	(7,342,000)
Cash flows from investing activities:
Payments to Develop Software	(144,000)	0
Purchases of marketable securities	(596,000)	0
Capital expenditures	(1,028,000)	(5,778,000)
Net cash used in investing activities	(1,768,000)	(6,778,000)
Cash flows from financing activities:
Proceeds from Lines of Credit	20,000,000	15,000,000
Repurchases of common stock	(14,787,000)	(22,282,000)
Excess tax benefit from share-based compensation	0	31,000
Proceeds from the exercise of stock options	29,000	1,117,000
Forfeiture of certain shares to satisfy exercise costs and the recipients income tax obligations related to stock options exercised and restricted stock vested	(66,000)	(1,117,000)
Dividend payments	(2,422,000)	(2,729,000)
Principal payments of debt obligations	0	(12,000)
Net cash provided by (used in) financing activities	2,754,000	(9,992,000)
Effect of foreign exchange rates on cash	321,000	(991,000)
Net change in cash and cash equivalents	11,841,000	(25,103,000)
Cash and cash equivalents at the beginning of the period	57,179,000	52,300,000
Cash and cash equivalents at the end of the period	69,020,000	27,197,000
Supplemental disclosures of cash flow information:
Interest paid	1,987,000	2,335,000
Income taxes paid	7,015,000	20,163,000
Via Media Health [Member]
Cash flows from investing activities:
Acquisition of business, net of cash acquired	$ 0	$ (1,000,000)